| UniProt ID | PDE9A_HUMAN | |
|---|---|---|
| UniProt AC | O76083 | |
| Protein Name | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A {ECO:0000305} | |
| Gene Name | PDE9A {ECO:0000312|HGNC:HGNC:8795} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 593 | |
| Subcellular Localization |
Isoform PDE9A1: Cell projection, ruffle membrane . Cytoplasm, perinuclear region . Golgi apparatus . Endoplasmic reticulum . Cell membrane, sarcolemma . Isoform PDE9A2: Cell projection, ruffle membrane . Cytoplasm, perinuclear region . Isoform PDE9A3: C |
|
| Protein Description | Specifically hydrolyzes the second messenger cGMP, which is a key regulator of many important physiological processes. Highly specific: compared to other members of the cyclic nucleotide phosphodiesterase family, has the highest affinity and selectivity for cGMP. [PubMed: 9624146] | |
| Protein Sequence | MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----MGSGSSSYRP -----CCCCCCCCCC | 33.92 | 23532336 | |
| 8 | Phosphorylation | MGSGSSSYRPKAIYL CCCCCCCCCCCEEEE | 32.65 | 23532336 | |
| 27 | Phosphorylation | RIQKVIFSKYCNSSD CEEHHHHHCCCCHHH | 16.16 | 24719451 | |
| 29 | Phosphorylation | QKVIFSKYCNSSDIM EHHHHHCCCCHHHHH | 8.82 | 17053785 | |
| 32 | Phosphorylation | IFSKYCNSSDIMDLF HHHCCCCHHHHHHHH | 26.31 | 24719451 | |
| 36 (in isoform 4) | Phosphorylation | - | 4.37 | - | |
| 43 | Phosphorylation | MDLFCIATGLPRNTT HHHHHHHHCCCCCCE | 21.24 | 24719451 | |
| 62 (in isoform 12) | Phosphorylation | - | 14.27 | - | |
| 76 | Phosphorylation | ANSERTPYKVRPVAI CCCCCCCCCCCCCHH | 22.85 | - | |
| 77 | Ubiquitination | NSERTPYKVRPVAIK CCCCCCCCCCCCHHH | 32.73 | - | |
| 87 | Phosphorylation | PVAIKQLSAGVEDKR CCHHHHHCCCCCCCC | 22.08 | - | |
| 111 (in isoform 5) | Phosphorylation | - | 4.11 | - | |
| 174 | Ubiquitination | AFKINELKAEVANHL HHHHHHHHHHHHHHH | 36.00 | - | |
| 186 | Ubiquitination | NHLAVLEKRVELEGL HHHHHHHHHHHHCCC | 58.54 | - | |
| 194 | Ubiquitination | RVELEGLKVVEIEKC HHHHCCCEEEEEEEC | 55.90 | - | |
| 224 | Ubiquitination | SRTNCPCKYSFLDNH CCCCCCCCCCCCCCC | 29.13 | - | |
| 379 | Phosphorylation | AVRYNDISPLENHHC EECCCCCCCCCCCCC | 26.71 | - | |
| 444 | Phosphorylation | EKMENFDYSNEEHMT HHHHCCCCCCHHHHH | 14.84 | - | |
| 508 | Phosphorylation | FMDRDKVTKATAQIG CCCHHHCHHHHHHHC | 22.24 | - | |
| 511 | Phosphorylation | RDKVTKATAQIGFIK HHHCHHHHHHHCCEE | 22.20 | - | |
| 567 | Phosphorylation | MKELQKKTDSLTSGA HHHHHHHHHHCCCCC | 37.54 | 22817900 | |
| 569 | Phosphorylation | ELQKKTDSLTSGATE HHHHHHHHCCCCCCH | 38.49 | 23312004 | |
| 571 | Phosphorylation | QKKTDSLTSGATEKS HHHHHHCCCCCCHHH | 29.12 | 22817900 | |
| 572 | Phosphorylation | KKTDSLTSGATEKSR HHHHHCCCCCCHHHH | 31.55 | 23312004 | |
| 578 | Phosphorylation | TSGATEKSRERSRDV CCCCCHHHHHHHHCC | 32.89 | 22817900 | |
| 582 | Phosphorylation | TEKSRERSRDVKNSE CHHHHHHHHCCCCCC | 28.25 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PDE9A_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PDE9A_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TRI32_HUMAN | TRIM32 | physical | 16189514 | |
| PHIPL_HUMAN | PHYHIPL | physical | 16189514 | |
| PDE9A_HUMAN | PDE9A | physical | 16189514 | |
| TRI32_HUMAN | TRIM32 | physical | 19060904 | |
| PDE9A_HUMAN | PDE9A | physical | 25416956 | |
| ST1E1_HUMAN | SULT1E1 | physical | 25416956 | |
| LAGE3_HUMAN | LAGE3 | physical | 25416956 | |
| BAG3_HUMAN | BAG3 | physical | 25416956 | |
| TRI32_HUMAN | TRIM32 | physical | 25416956 | |
| GORS2_HUMAN | GORASP2 | physical | 25416956 | |
| TRPV6_HUMAN | TRPV6 | physical | 25416956 | |
| KRA92_HUMAN | KRTAP9-2 | physical | 25416956 | |
| UTP23_HUMAN | UTP23 | physical | 25416956 | |
| LSMD1_HUMAN | NAA38 | physical | 25416956 | |
| PHIPL_HUMAN | PHYHIPL | physical | 25416956 | |
| KRA42_HUMAN | KRTAP4-2 | physical | 25416956 | |
| KR108_HUMAN | KRTAP10-8 | physical | 25416956 | |
| KR103_HUMAN | KRTAP10-3 | physical | 25416956 | |
| NT2NL_HUMAN | NOTCH2NL | physical | 25416956 | |
| CI106_HUMAN | C9orf106 | physical | 25416956 | |
| TFAP4_HUMAN | TFAP4 | physical | 21516116 |
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| There are no disease associations of PTM sites. | |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB00201 | Caffeine |
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Tyrosine phosphorylated Par3 regulates epithelial tight junctionassembly promoted by EGFR signaling."; Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A.,Lottspeich F., Chen Z.; EMBO J. 25:5058-5070(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-29, AND MASSSPECTROMETRY. | |